Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-20-003590)

Filing Details

Accession Number:: 0001179110-20-003590
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-12 19:01:27
Reporting Period:: 2020-03-10

Accepted Time:: 2020-03-12 19:01:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271244	Richard Christopher	C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139	Cfo And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-10	3,636	$0.00	5,220	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2020-03-10	3,636	$0.00	3,636	$2.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,636	2020-03-10	2025-03-10	No	4	P	Direct

Footnotes

The reported securities were sold together at a combined purchase price of $2.75 per share of common stock and warrant to purchase one share of common stock.